GOLGA6L10
gene geneOn this page
Summary
GOLGA6L10 (golgin A6 family like 10, HGNC:37228) is a protein-coding gene on chromosome 15q25.2, encoding Golgin subfamily A member 6-like protein 10 (A6NI86).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 90 total
- MANE Select transcript:
NM_001164465
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37228 |
| Approved symbol | GOLGA6L10 |
| Name | golgin A6 family like 10 |
| Location | 15q25.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000278662 |
| Ensembl biotype | protein_coding |
| Entrez | 647042 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000558035, ENST00000610657, ENST00000621197
RefSeq mRNA: 1 — MANE Select: NM_001164465
NM_001164465
CCDS: CCDS45325
Canonical transcript exons
ENST00000610657 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002255247 | 82349292 | 82349475 |
| ENSE00002468223 | 82339993 | 82342908 |
| ENSE00003716763 | 82345809 | 82345896 |
| ENSE00003726768 | 82344261 | 82344321 |
| ENSE00003733128 | 82343118 | 82343220 |
| ENSE00003737818 | 82347510 | 82347629 |
| ENSE00003747884 | 82346827 | 82346886 |
| ENSE00003752769 | 82346561 | 82346641 |
| ENSE00003753750 | 82344588 | 82345426 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 80.65.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 80.65 | gold quality |
| left testis | UBERON:0004533 | 80.20 | gold quality |
| right testis | UBERON:0004534 | 80.03 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.69 | gold quality |
| right uterine tube | UBERON:0001302 | 79.59 | gold quality |
| testis | UBERON:0000473 | 79.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.23 | gold quality |
| left ovary | UBERON:0002119 | 77.25 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.15 | gold quality |
| esophagus mucosa | UBERON:0002469 | 76.11 | gold quality |
| vagina | UBERON:0000996 | 75.76 | gold quality |
| ovary | UBERON:0000992 | 75.73 | gold quality |
| ectocervix | UBERON:0012249 | 75.68 | gold quality |
| right ovary | UBERON:0002118 | 74.73 | gold quality |
| uterine cervix | UBERON:0000002 | 74.27 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.24 | gold quality |
| endocervix | UBERON:0000458 | 73.95 | gold quality |
| body of uterus | UBERON:0009853 | 73.67 | gold quality |
| esophagus | UBERON:0001043 | 73.39 | gold quality |
| endometrium | UBERON:0001295 | 73.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.28 | gold quality |
| minor salivary gland | UBERON:0001830 | 73.28 | gold quality |
| ventricular zone | UBERON:0003053 | 72.59 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.50 | gold quality |
| left uterine tube | UBERON:0001303 | 72.45 | gold quality |
| myometrium | UBERON:0001296 | 72.17 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 72.16 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 71.86 | gold quality |
| body of pancreas | UBERON:0001150 | 70.61 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 70.61 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
110 targeting GOLGA6L10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
Cross-species orthologs
0 orthologs
Paralogs (10): GOLGA6L2 (ENSG00000174450), GOLGA6L4 (ENSG00000184206), GOLGA6L9 (ENSG00000197978), GOLGA6L25 (ENSG00000227717), GOLGA6L24 (ENSG00000237850), GOLGA6L7 (ENSG00000261649), GOLGA6L26 (ENSG00000273756), GOLGA6L1 (ENSG00000273976), GOLGA6L6 (ENSG00000277322), GOLGA6L22 (ENSG00000277865)
Protein
Protein identifiers
Golgin subfamily A member 6-like protein 10 — A6NI86 (reviewed: A6NI86)
All UniProt accessions (2): A6NI86, A0A087X1J3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GOLGA6 family.
RefSeq proteins (1): NP_001157937* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026737 | GOLGA6L | Family |
| IPR043976 | GOLGA_cons_dom | Domain |
Pfam: PF15070
UniProt features (9 total): compositionally biased region 5, region of interest 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NI86-F1 | 75.57 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
MIR607, MIR3646, MIR520D_5P, MIR524_5P, MIR4719, MIR494_3P, MIR543, MIR302A_5P, MIR5701, MIR548AO_5P_MIR548AX, MIR3192_5P, MIR4424, MIR5693, MIR6822_3P, MIR296_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
608 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GOLGA6L10 | SPDYE5 | A6NIY4 | 507 |
| GOLGA6L10 | ZBED11 | P0CF97 | 477 |
| GOLGA6L10 | OR5P2 | Q8WZ92 | 436 |
| GOLGA6L10 | FAM228B | P0C875 | 432 |
| GOLGA6L10 | CLEC19A | Q6UXS0 | 420 |
| GOLGA6L10 | FOXD4L3 | Q6VB84 | 417 |
| GOLGA6L10 | ANKRD45 | Q5TZF3 | 402 |
| GOLGA6L10 | C1orf198 | Q9H425 | 396 |
| GOLGA6L10 | H3BVE0 | H3BVE0 | 321 |
| GOLGA6L10 | BRINP2 | Q9C0B6 | 311 |
| GOLGA6L10 | NBPF1 | Q3BBV0 | 307 |
| GOLGA6L10 | SYNDIG1 | Q9H7V2 | 306 |
| GOLGA6L10 | UBXN11 | Q5T124 | 299 |
| GOLGA6L10 | PKD1L3 | Q7Z443 | 292 |
| GOLGA6L10 | SPACA7 | Q96KW9 | 289 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLGA6L10 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| GOLGA6L10 | psi-mi:“MI:0915”(physical association) | 0.370 |
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A5D7L8, A6NEF3, A6NI86, B2KFW1, B4DH59, D3YZV8, E9Q6E9, F1LWT0, F6QRE9, H0YKK7, O15069, P17040, P17564, P21263, P51843, P62521, P79386, Q0P6D6, Q13342, Q2EG98, Q2KI51, Q3BBV2, Q4VC44, Q5F378, Q5QGU6, Q63560, Q6ITT4, Q6P5H2, Q6ZQX7, Q86T75, Q8CHD8, Q8IWY8, Q8N660, Q8N693, Q99PG2, Q9BE18, Q9BG93, Q9BG94
Diamond homologs: A0A1B0GV03, A1IH00, A6NC78, A6NCC3, A6NDK9, A6NDN3, A6NEF3, A6NEM1, A6NI86, A6NN73, A7E2F4, A8MQT2, A8MZA4, F8WBI6, H0YKK7, H0YM25, H3BPF8, H3BSY2, H3BV12, I6L899, P0CG33, P0CJ92, P0DX00, P0DX01, P0DX02, P0DX52, P0DX53, Q08379, Q62839, Q8N7Z2, Q8N9W4, Q921M4, Q9NYA3, A6NMD2, D6RF30, H3BQL2, Q0D2H9, Q9HBQ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 14 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1298 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:82343114:TCA:T | donor_loss | 1.0000 |
| 15:82343115:CAC:C | donor_loss | 1.0000 |
| 15:82343116:ACCAC:A | donor_gain | 1.0000 |
| 15:82343117:CCA:C | donor_gain | 1.0000 |
| 15:82343117:CCACC:C | donor_gain | 1.0000 |
| 15:82344318:TGTT:T | acceptor_gain | 1.0000 |
| 15:82344321:TC:T | acceptor_loss | 1.0000 |
| 15:82344322:C:CC | acceptor_gain | 1.0000 |
| 15:82344322:CT:C | acceptor_loss | 1.0000 |
| 15:82344584:GTACC:G | donor_loss | 1.0000 |
| 15:82344585:TACC:T | donor_loss | 1.0000 |
| 15:82344586:A:AC | donor_gain | 1.0000 |
| 15:82344586:A:T | donor_loss | 1.0000 |
| 15:82344587:C:CG | donor_gain | 1.0000 |
| 15:82344587:CCAG:C | donor_gain | 1.0000 |
| 15:82345807:AC:A | donor_gain | 1.0000 |
| 15:82345808:CC:C | donor_gain | 1.0000 |
| 15:82345808:CCCGT:C | donor_gain | 1.0000 |
| 15:82345896:CCTG:C | acceptor_loss | 1.0000 |
| 15:82345897:CTGC:C | acceptor_loss | 1.0000 |
| 15:82345902:C:T | acceptor_gain | 1.0000 |
| 15:82346651:A:C | acceptor_gain | 1.0000 |
| 15:82346678:T:TC | acceptor_gain | 1.0000 |
| 15:82346886:AC:A | acceptor_loss | 1.0000 |
| 15:82346887:C:CC | acceptor_gain | 1.0000 |
| 15:82347505:CTCA:C | donor_loss | 1.0000 |
| 15:82347506:TCACA:T | donor_loss | 1.0000 |
| 15:82347507:CA:C | donor_loss | 1.0000 |
| 15:82347507:CAC:C | donor_loss | 1.0000 |
| 15:82347508:A:AC | donor_gain | 1.0000 |
AlphaMissense
3394 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:82342783:A:G | I521T | 0.957 |
| 15:82344639:C:A | W407C | 0.942 |
| 15:82344639:C:G | W407C | 0.942 |
| 15:82342783:A:C | I521S | 0.929 |
| 15:82342783:A:T | I521N | 0.919 |
| 15:82349372:A:G | W2R | 0.915 |
| 15:82349372:A:T | W2R | 0.915 |
| 15:82344641:A:G | W407R | 0.910 |
| 15:82344641:A:T | W407R | 0.910 |
| 15:82344844:A:G | L339P | 0.905 |
| 15:82342789:A:G | I519T | 0.884 |
| 15:82344597:G:C | F421L | 0.865 |
| 15:82344597:G:T | F421L | 0.865 |
| 15:82344599:A:G | F421L | 0.865 |
| 15:82345354:A:G | L169P | 0.848 |
| 15:82349298:C:A | K26N | 0.847 |
| 15:82349298:C:G | K26N | 0.847 |
| 15:82347628:A:G | L29S | 0.841 |
| 15:82344766:A:G | L365P | 0.835 |
| 15:82342789:A:C | I519S | 0.830 |
| 15:82344652:A:G | L403P | 0.825 |
| 15:82344664:A:G | L399P | 0.821 |
| 15:82345321:A:G | L180P | 0.820 |
| 15:82349370:C:A | W2C | 0.818 |
| 15:82349370:C:G | W2C | 0.818 |
| 15:82344673:A:G | L396P | 0.817 |
| 15:82344996:C:A | Q288H | 0.814 |
| 15:82344996:C:G | Q288H | 0.814 |
| 15:82345027:A:G | L278P | 0.813 |
| 15:82345038:C:A | Q274H | 0.811 |
dbSNP variants (sampled 300 via entrez): RS1004202609 (15:82350691 T>C), RS1008347756 (15:82345114 C>A), RS1008419857 (15:82340982 T>C), RS1015671255 (15:82345346 C>A,G), RS1015744833 (15:82342460 G>A,C), RS1023859179 (15:82339588 AG>A), RS1024306781 (15:82350611 G>C), RS1027659498 (15:82345824 G>C), RS1041085704 (15:82345800 C>G), RS1045554101 (15:82343918 C>G,T), RS1047165078 (15:82350487 G>A), RS1049662523 (15:82347003 C>A,T), RS1054259384 (15:82346795 G>A), RS1054817181 (15:82344855 C>T), RS111590690 (15:82347856 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007277_21 | Tourette syndrome | 7.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| Cadmium | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.